Free Trial

CNS Pharmaceuticals (CNSP) Insider Trading & Ownership

CNS Pharmaceuticals logo
$6.70 -0.29 (-4.15%)
Closing price 04:00 PM Eastern
Extended Trading
$6.88 +0.18 (+2.69%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CNS Pharmaceuticals (NASDAQ:CNSP) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
0.07%
Number Of
Insiders Buying
(Last 3 Years)
3
Number Of
Insiders Selling
(Last 3 Years)
1
Get CNSP Insider Trade Alerts

Want to know when executives and insiders are buying or selling CNS Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CNSP Insider Buying and Selling by Quarter

CNS Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/22/2023Christopher DownsCFOBuy0$38,100.00$0.00  
8/16/2023John M ClimacoCEOBuy0$54,000.00$0.00  
4/19/2023Jerzy GumulkaDirectorBuy0$51,000.00$0.00  
4/17/2023Christopher DownsCFOBuy0$96,000.00$0.00  
4/12/2023John M ClimacoCEOBuy0$20,700.00$0.00  
4/10/2023Jerzy GumulkaDirectorBuy0$22,200.00$0.00  
3/27/2023Waldemar PriebeMajor ShareholderSell0$32,700.00$0.00  
3/24/2023Waldemar PriebeMajor ShareholderSell0$32,400.00$0.00  
3/22/2023Waldemar PriebeMajor ShareholderSell0$32,400.00$0.00  
3/20/2023Waldemar PriebeMajor ShareholderSell0$32,400.00$0.00  
3/17/2023Waldemar PriebeMajor ShareholderSell0$33,900.00$0.00  
3/15/2023Waldemar PriebeMajor ShareholderSell0$36,600.00$0.00  
3/13/2023Waldemar PriebeMajor ShareholderSell0$39,000.00$0.00  
3/10/2023Waldemar PriebeMajor ShareholderSell0$38,700.00$0.00  
(Data available from 1/1/2013 forward)

CNSP Insider Trading Activity - Frequently Asked Questions

The list of insiders at CNS Pharmaceuticals includes Christopher Downs, Jerzy Gumulka, John M Climaco, and Waldemar Priebe. Learn more on insiders at CNSP.

0.07% of CNS Pharmaceuticals stock is owned by insiders. Learn more on CNSP's insider holdings.

The following insiders have purchased CNSP shares in the last 24 months: Christopher Downs ($0.00), and John M Climaco ($0.00).

Insiders have purchased a total of 0 CNSP shares in the last 24 months for a total of $0.00 bought.

CNS Pharmaceuticals Key Executives



This page (NASDAQ:CNSP) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners